Sandeep Mhetre has assumed the position of Chief Scientific Officer at Rising Pharmaceuticals, bringing years of vast experience in the pharmaceutical industry. His expertise is set to significantly enhance Rising’s R&D capabilities and fortify its stance in the niche and complex generics market in the U.S.
Previously serving as Senior Vice President at Novugen Pharma, Sandeep has worked closely with the leadership team and Board members to orchestrate their global R&D canter, expand Novugen’s product portfolio and build technical competency for global markets. His tenure was marked by stringent adherence to global regulatory standards, particularly those governing the U.S. pharmaceutical market.Sandeep’s illustrious career includes prominent roles at Biocon, Dr. Reddy’s, Ranbaxy, etc. His leadership in end to end solutions from product screening to commercial launch has established him as a distinguished figure in the industry.
At Rising Pharmaceuticals, Sandeep will drive R&D initiatives, accelerating product development, enhancing technical capabilities, and maintaining compliance with USFDA standards. Sandeep’s techno-commercial acumen will be instrumental in navigating the complexities of the U.S. generics market.
His leadership, cantered on innovation, efficiency and operational excellence, would align with Rising Pharmaceuticals’ mission to deliver high-quality, cost-effective medicines across the US market.
